As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

The Decentralized Clinical Trials market, valued at USD 8.87 billion in 2024, is expected to register revenue CAGR of 10.2%.Request free copy of this report: 05, 2026- Growing demand for ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

BERWYN, PA — Mural Health announced it has expanded global payment capabilities within its Mural Link participant management ...

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, discusses how growing FDA support is accelerating the adoption of Bayesian approaches, enabling more flexible, ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Changes To UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions Of UK Model Clinical Trial Agreement Forms Pending. Legal News and Analysis - United Kingdom - Regulatory & Complianc ...

A GP practice near Edinburgh has launched its own dedicated nurse-led clinical research facility, with the hope that others will follow suit.

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...